NewsRelease
ApplicationsReport Highlights Advantages of Evaluating Both AlbuSorb™ PLUS andAlbuVoid™ PLUS in Serum Proteomic Workflows
MONMOUTHJUNCTION, NJ,August2, 2019 -- Biotech Support Group reports on a new applications reportwhich highlights the simplicity and efficiency of their Albumin &IgG depletion sample preparation technology as an enrichment step forhuman serum using LC-MS proteomic analysis. The title of the reportis:
“AlbuVoid™PLUS & AlbuSorb™ PLUS - Evaluating Different Windows ofObservation Solves The Many Challenges of Serum Proteomics”
Andcan be downloaded at:
Forserum, many proteomic enrichment strategies employ the use ofimmuno-affinity depletion to remove one or more high abundanceproteins. Some common limitations of immuno-affinity however are highcosts, and regeneration requirements which may result in a diminishedand inconsistent performance. Because of these limitations, proteomicresearchers need ways to enrich without immuno-affinity.Thisreport considers the advantages of first reducing the influence ofIgGs- a heterogeneous and proteolytically resistant class ofproteins, along with Albumin depletion. Two products - AlbuVoid™PLUS & AlbuSorb™ PLUS support depletion of both Albumin andIgG, through different strategies and workflows. Using LC-MSreporting metrics, the report highlights the serum sub-proteome biascharacteristics of these products. Some examples of their selectiveutility for biomarker discovery in cancer are also presented.
“Throughoutour product and methods development efforts, we have been especiallyfocused on overcoming the challenges of clinical proteomics. Forthis, our central technology focus is to develop highly selectiveseparations products that do not rely on immuno-affinity. These canoffer many advantages necessary to transition from discovery ofbiomarkers to robust quantitation of clinically useful biomarkers. Iam pleased that this report highlights these advantages.” statesSwapan Roy, Ph.D., President and Founder of Biotech Support Group.
Formore information on the BSG complete line of Albumin& IgG Removal products,visit:https://www.biotechsupportgroup.com/Articles.asp?ID=451
AboutBiotech Support Group LLC
Convergingwith cultural and technological disruptions forthcoming inhealthcare, Biotech Support Group develops methods for cost effectiveand efficient sample prep essential for these expanding markets.Following a tiered business strategy, the company continues itsgrowth in the consumable research products area supporting therapidly expanding installation of LC-MS instrument and computationalinfrastructure. For this market, key products include: AlbuVoid™and AlbuSorb™ for albumin depletion, Cleanascite™ for lipidadsorption, HemogloBind™ and HemoVoid™ for hemoglobin removal,and NuGel™ for functional proteomics. From these innovations, thecompany has acquired knowledgebase and biomarker intellectualproperty assets that support discoveries of protein markers fromblood, with special emphasis on early detection and personalizedmedical decisions for cancer patients. For more information, gotohttp://www.biotechsupportgroup.com/.
ForBusiness Development,Contact:MattKuruc 732-274-2866, [email protected]